These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 37047309)

  • 21. LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease.
    Nguyen M; Krainc D
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5576-5581. PubMed ID: 29735704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysfunction of Synaptic Vesicle Endocytosis in Parkinson's Disease.
    Zou L; Tian Y; Zhang Z
    Front Integr Neurosci; 2021; 15():619160. PubMed ID: 34093144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rare Variants Analysis of Lysosomal Related Genes in Early-Onset and Familial Parkinson's Disease in a Chinese Cohort.
    Chen YP; Gu XJ; Song W; Hou YB; Ou RW; Zhang LY; Liu KC; Su WM; Cao B; Wei QQ; Zhao B; Wu Y; Shang HF
    J Parkinsons Dis; 2021; 11(4):1845-1855. PubMed ID: 34250953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinson's Disease Genetics and Pathophysiology.
    Vázquez-Vélez GE; Zoghbi HY
    Annu Rev Neurosci; 2021 Jul; 44():87-108. PubMed ID: 34236893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's Disease Gene Screening in Familial Cases from Central and South America.
    Lorenzo-Betancor O; Mehta S; Ramchandra J; Mumuney S; Schumacher-Schuh AF; Cornejo-Olivas M; Sarapura-Castro EH; Torres L; Inca-Martinez MA; Mazzetti P; Cosentino C; Micheli F; Tumas V; Dieguez E; Raggio V; Borges V; Ferraz HB; Chana-Cuevas P; Jimenez-Del-Rio M; Velez-Pardo C; Moreno S; Lopera F; Orozco-Velez JL; Muñoz-Ospina B; Rieder CRM; Medina-Escobar A; Yearout D; Zabetian CP; Mata IF;
    Mov Disord; 2024 Jul; ():. PubMed ID: 39051491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism and therapeutic targets of the involvement of a novel lysosomal proton channel TMEM175 in Parkinson's disease.
    Feng T; Zheng H; Zhang Z; Fan P; Yang X
    Ageing Res Rev; 2024 Sep; 100():102373. PubMed ID: 38960046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of Parkinson's disease: the yield.
    Spatola M; Wider C
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S35-8. PubMed ID: 24262184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance.
    Hernandez DG; Reed X; Singleton AB
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):59-74. PubMed ID: 27090875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila.
    Inoshita T; Arano T; Hosaka Y; Meng H; Umezaki Y; Kosugi S; Morimoto T; Koike M; Chang HY; Imai Y; Hattori N
    Hum Mol Genet; 2017 Aug; 26(15):2933-2948. PubMed ID: 28482024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the focal role of LRRK2 kinase in Parkinson's disease.
    Kumar S; Behl T; Sehgal A; Chigurupati S; Singh S; Mani V; Aldubayan M; Alhowail A; Kaur S; Bhatia S; Al-Harrasi A; Subramaniyan V; Fuloria S; Fuloria NK; Sekar M; Abdel Daim MM
    Environ Sci Pollut Res Int; 2022 May; 29(22):32368-32382. PubMed ID: 35147886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting of Lysosomal Pathway Genes for Parkinson's Disease Modification: Insights From Cellular and Animal Models.
    Abe T; Kuwahara T
    Front Neurol; 2021; 12():681369. PubMed ID: 34194386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy and Parkinson's Disease.
    Lu J; Wu M; Yue Z
    Adv Exp Med Biol; 2020; 1207():21-51. PubMed ID: 32671737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction.
    Bellomo G; Paciotti S; Gatticchi L; Parnetti L
    Mov Disord; 2020 Jan; 35(1):34-44. PubMed ID: 31729779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of Parkinson's disease.
    Cherian A; Divya KP
    Acta Neurol Belg; 2020 Dec; 120(6):1297-1305. PubMed ID: 32813147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.
    Martin S; Smolders S; Van den Haute C; Heeman B; van Veen S; Crosiers D; Beletchi I; Verstraeten A; Gossye H; Gelders G; Pals P; Hamouda NN; Engelborghs S; Martin JJ; Eggermont J; De Deyn PP; Cras P; Baekelandt V; Vangheluwe P; Van Broeckhoven C;
    Acta Neuropathol; 2020 Jun; 139(6):1001-1024. PubMed ID: 32172343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease.
    Gan-Or Z; Dion PA; Rouleau GA
    Autophagy; 2015; 11(9):1443-57. PubMed ID: 26207393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkinson's: A Disease of Aberrant Vesicle Trafficking.
    Singh PK; Muqit MMK
    Annu Rev Cell Dev Biol; 2020 Oct; 36():237-264. PubMed ID: 32749865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression.
    Henry AG; Aghamohammadzadeh S; Samaroo H; Chen Y; Mou K; Needle E; Hirst WD
    Hum Mol Genet; 2015 Nov; 24(21):6013-28. PubMed ID: 26251043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
    Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
    Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.